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Purpose/Objective: Film dosimetry with Gafchromic EBT3 
represents a widespread tool to assess dose distributions in 
conventional Radiotherapy. Their use becomes more difficult 
in RadioSurgery and Hypofractionated Radiotherapy, where 
high doses per fraction are delivered and film sensitivity is 
limited. 
Aim of this work is to propose and validate a novel and 
comprehensive dosimetric approach, implementing the 
innovative Sum Signal (SS) method to increase film sensitivity 
and effectively extend EBT3 use also to high dose patient 
specific Quality Assurance (QA). 
Materials and Methods: To characterize film dose response, 
3x3cm2 films were irradiated with a 6MV photon beam 
(range: 0-24Gy), contextually measuring delivered doses with 
an ionization chamber. Films were digitized to obtain net 
optical densities (netOD) for Red Channel (RC) and Green 
Channel (GC). The SS was calculated by linearly summing the 
netOD values obtained for RC and GC. 
 
Calibration data were fitted using the effective variance 
method, which takes into account the uncertainties of net OD 
(σy,i) and of dose values (σx,i) by performing a fit with weights 
wi based on the effective uncertainties σy,i,eff 
 
The best fitting function was selected according to the 
Akaike Information Criterion (AIC), which ensures the best 
compromise between goodness of fit and number of fit 
parameter used. According to this criterion, the best fit 
function is the one showing the lowest AICc value: 
 
where k is the number of parameters in the fit function, χ2 is 
the reduced chi-square value and the last one is a correction 
term for finite samples. 
An homemade Matlab software was contextually developed to 
compare, in terms of gamma analysis, dose distributions 
delivered by a Cyberknife system on EBT3 films to those 
calculated by the treatment planning system. 
The new SS method and the conventional Single Channel (SC) 
one (consisting in using the RC for doses <10Gy and the GC 
for higher doses) were implemented in this software and 
compared calculating the % of γ points <1 for 20 patient plans 
with maximum planned dose range 6-21 Gy. 
The statistical relevance of the differences between the two 
methods was evaluated by the Wilcoxon signed-rank test.  
Results: Our analysis shows that the SS dose-response curve 
is characterized by a steeper trend in comparison with SC 
ones, providing higher dose accuracy in a broader dose range. 
 
Best-fit analysis by AICc value shows that the double 
exponential function is able to fit the whole film dose 
response object of this study. 
The impact of the increase in sensitivity using SS was 
confirmed by the Gamma analysis, which shows that the % of 
γ points satisfying agreement criteria is significantly higher 
for the SS method with respect to the SC approach both for 
3%-1mm and 4%-1mm acceptance criteria:  
 
Conclusions: The results demonstrate that the developed 
protocol implementing SS can be considered a novel and 
promising actor, able to improve dosimetric accuracy for high 
dose patient specific QA.  
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Purpose/Objective: Proton therapy is sensitive to range 
uncertainties. These uncertainties can be reduced by on-line 
in vivo monitoring of the range, which is possible by imaging 
the prompt gammas (PG) emitted by the protons. A recently 
developed PG camera prototype showed a 1-2 mm accuracy 
to detect range shifts at clinical beam currents. The range 
shift is determined by comparing a reference signal 
computed in patient geometry to a measured one. The 
reference signal should be ideally computed for all scanned 
spots for further selection of the most adequate probe spots 
to verify the range when the patient is on couch. Because of 
the huge number of spots (> 1000, typically), we 
implemented an analytical model much faster than lengthy 
Monte Carlo simulations (MC).  
Materials and Methods: The geometrical details of the 
camera are shown in the figure (part (a)). The analytical 
model computes the PG detection signal by 1) composition-
weighted addition of MC PG emission profiles previously 
generated in either 12C, 14N, 16O, 31P or 40Ca; and 2) 
convolution of the emission signal by a transfer function of 
the camera. For the generation of reference PG emission 
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profiles, the MC code used was PENELOPE extended to 
protons (PENH). The transfer function is obtained from 
interpolation of a table of analytical fits to previously MC 
simulated responses of the camera. Optical and spectral 
properties of the incident proton beam are also taken into 
account in both MC and analytical models. Neutrons 
contribute to the total signal as a flat background with 
notable uncertainties and with no impact on the range shift 
estimation and are therefore not simulated.The analytical 
model was benchmarked against MC simulations and 
experiments for various configurations of a cylindrical 
phantom with inserts of different tissue-equivalent materials. 
It was also benchmarked against MC in patients. We present 
here the results for a critical configuration as shown in the 
figure (part (b)). The proton incident energy was set to 110 
MeV. Protons are expected to stop at the interface between 
muscle (G452) and lung (LN 300) equivalent tissues. 
Results: For the results shown in the figure (part (c)), 
excellent agreement is observed between the analytical 
model and MC: 99.7% of the points for PG emission passing a 
gamma 3%/1 mm criteria and an agreement within 0.6 mm 
for the estimation of range shifts. Agreement between the 
analytical model and measurements (MS) is within 0.4 mm for 
range shifts. The measured signal was corrected for the 
contribution of the neutrons by matching the average of 
measured values to the average of MC values. Typical 
computing time for the analytical model is between 50 to 150 
ms for a single spot. 
Conclusions: A fast and accurate analytical model has been 
validated in phantom and CT geometries for an existing 
prompt gamma camera prototype. The analytical model can 
now be used for future implementation of the system in 
clinical practice.  
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Purpose/Objective: Measuring, calculating, and reducing 
non-target doses present unique challenges with which many 
medical physicists may have limited experience with. The 
American Association of Physicists in Medicine Task Group 
(TG) 158, measurement and calculation of doses outside the 
treatment volume from external-beam radiation therapy 
(EBRT), was created to provide guidance for physicists in 
assessing and managing non-target doses. The primary 
objective of this presentation is to discuss uses of 
dosimeters and phantoms for measuring non-target doses 
from photon, electron, and light-ion EBRT.  
Materials and Methods: The TG-158 reviewed approximately 
300 publications in the literature, twenty percent of which 
focused on measurement techniques, detectors, and 
phantoms for assessment of non-target doses. This 
presentation will highlight key components of Chapter 4 of 
TG-158 report, measurement approaches.  
Results: For measurements of non-target dose in photon and 
electron therapy, the following detectors will be discussed: 
thermo luminescent and optically luminescent dosimeters, 
diodes, metal oxide-silicon semiconductor field effect 
transistor dosimeters, and ion chambers. The use of each 
dosimeter will be presented in the context of (1) dose at the 
surface, (2) energy spectrum, (3) dosimeter dynamic range, 
and (4) presence of other particles.  
This presentation will also summarize various detectors that 
can be used to measure secondary neutrons. Neutron 
detectors are highly energy dependent and thus, knowledge 
of the energy spectrum being measured is essential. The 
secondary neutrons from electron, photon, and light-ion 
therapy have a wide energy range, i.e., from thermal up to 
about 10 MV for photon/electron therapy and thermal up to 
250 MeV for light ion therapy. Moreover, many neutron 
detectors cannot be used in or near the primary field because 
of issues such as pulse-pile-up and interactions of particles 
within the detector, among others. Thus, each neutron 
detector will be presented in the context of its energy 
sensitivity and its suitability for measurements in-or near the 
primary field. 
Finally, the presentation will highlight various issues related 
to phantom selection, including assumptions about organ 
position within anthropomorphic phantoms, adult verses 
pediatric phantoms, and effect of phantoms on neutron 
energy spectra. 
Conclusions: This presentation will highlight the unique 
challenges of measuring non-target doses and will provide 
guidance on how to select the most appropriate detector and 
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Purpose/Objective: Validation of the Radiation Therapy 
Oncology Group (RTOG)-endorsed guidelines (Table 1) for 
brachial plexus (BP) contouring by determining the intra- and 
interobserver agreement. Anatomically validated computed 
tomography (CT) and magnetic resonance imaging (MRI) 
datasets were used as a gold standard to determine the 
accuracy of the delineation process. Validation of the BP was 
performed by dissection of all cadavers. 
Materials and Methods: The right BP was delineated on 3 CT 
cadaver datasets by 5 observers. Inter- and intraobserver 
variation was computed using the Computerized Environment 
for Radiation Research (CERR) package. Each observer 
